Cargando…

Lost in the shadows: reflections on the dark side of co-production

This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Oli, Sarre, Sophie, Papoulias, Stan Constantina, Knowles, Sarah, Robert, Glenn, Beresford, Peter, Rose, Diana, Carr, Sarah, Kaur, Meerat, Palmer, Victoria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204208/
https://www.ncbi.nlm.nih.gov/pubmed/32380998
http://dx.doi.org/10.1186/s12961-020-00558-0
_version_ 1783530017389543424
author Williams, Oli
Sarre, Sophie
Papoulias, Stan Constantina
Knowles, Sarah
Robert, Glenn
Beresford, Peter
Rose, Diana
Carr, Sarah
Kaur, Meerat
Palmer, Victoria J.
author_facet Williams, Oli
Sarre, Sophie
Papoulias, Stan Constantina
Knowles, Sarah
Robert, Glenn
Beresford, Peter
Rose, Diana
Carr, Sarah
Kaur, Meerat
Palmer, Victoria J.
author_sort Williams, Oli
collection PubMed
description This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-produce health research, including highlighting various professional costs to those involved. However, we identify four related limitations in their inquiry, as follows: (1) the adoption of a problematically expansive definition of co-production that fails to acknowledge key features that distinguish co-production from broader collaboration; (2) a strong focus on technocratic rationales for co-producing research and a relative neglect of democratic rationales; (3) the transposition of legitimate concerns relating to collaboration between researchers and practitioners onto work with patients, service users and marginalised citizens; and (4) the presentation of bad practice as an inherent flaw, or indeed ‘dark side’, of co-production without attending to the corrupting influence of contextual factors within academic research that facilitate and even promote such malpractice. The Commentary’s limitations can be seen to reflect the contemporary use of the term ‘co-production’ more broadly. We describe this phenomenon as ‘cobiquity’ – an apparent appetite for participatory research practice and increased emphasis on partnership working, in combination with the related emergence of a plethora of ‘co’ words, promoting a conflation of meanings and practices from different collaborative traditions. This phenomenon commonly leads to a misappropriation of the term ‘co-production’. Our main motivation is to address this imprecision and the detrimental impact it has on efforts to enable co-production with marginalised and disadvantaged groups. We conclude that Oliver et al. stray too close to ‘the problem’ of ‘co-production’ seeing only the dark side rather than what is casting the shadows. We warn against such a restricted view and argue for greater scrutiny of the structural factors that largely explain academia’s failure to accommodate and promote the egalitarian and utilitarian potential of co-produced research.
format Online
Article
Text
id pubmed-7204208
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72042082020-05-12 Lost in the shadows: reflections on the dark side of co-production Williams, Oli Sarre, Sophie Papoulias, Stan Constantina Knowles, Sarah Robert, Glenn Beresford, Peter Rose, Diana Carr, Sarah Kaur, Meerat Palmer, Victoria J. Health Res Policy Syst Commentary This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-produce health research, including highlighting various professional costs to those involved. However, we identify four related limitations in their inquiry, as follows: (1) the adoption of a problematically expansive definition of co-production that fails to acknowledge key features that distinguish co-production from broader collaboration; (2) a strong focus on technocratic rationales for co-producing research and a relative neglect of democratic rationales; (3) the transposition of legitimate concerns relating to collaboration between researchers and practitioners onto work with patients, service users and marginalised citizens; and (4) the presentation of bad practice as an inherent flaw, or indeed ‘dark side’, of co-production without attending to the corrupting influence of contextual factors within academic research that facilitate and even promote such malpractice. The Commentary’s limitations can be seen to reflect the contemporary use of the term ‘co-production’ more broadly. We describe this phenomenon as ‘cobiquity’ – an apparent appetite for participatory research practice and increased emphasis on partnership working, in combination with the related emergence of a plethora of ‘co’ words, promoting a conflation of meanings and practices from different collaborative traditions. This phenomenon commonly leads to a misappropriation of the term ‘co-production’. Our main motivation is to address this imprecision and the detrimental impact it has on efforts to enable co-production with marginalised and disadvantaged groups. We conclude that Oliver et al. stray too close to ‘the problem’ of ‘co-production’ seeing only the dark side rather than what is casting the shadows. We warn against such a restricted view and argue for greater scrutiny of the structural factors that largely explain academia’s failure to accommodate and promote the egalitarian and utilitarian potential of co-produced research. BioMed Central 2020-05-07 /pmc/articles/PMC7204208/ /pubmed/32380998 http://dx.doi.org/10.1186/s12961-020-00558-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Williams, Oli
Sarre, Sophie
Papoulias, Stan Constantina
Knowles, Sarah
Robert, Glenn
Beresford, Peter
Rose, Diana
Carr, Sarah
Kaur, Meerat
Palmer, Victoria J.
Lost in the shadows: reflections on the dark side of co-production
title Lost in the shadows: reflections on the dark side of co-production
title_full Lost in the shadows: reflections on the dark side of co-production
title_fullStr Lost in the shadows: reflections on the dark side of co-production
title_full_unstemmed Lost in the shadows: reflections on the dark side of co-production
title_short Lost in the shadows: reflections on the dark side of co-production
title_sort lost in the shadows: reflections on the dark side of co-production
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204208/
https://www.ncbi.nlm.nih.gov/pubmed/32380998
http://dx.doi.org/10.1186/s12961-020-00558-0
work_keys_str_mv AT williamsoli lostintheshadowsreflectionsonthedarksideofcoproduction
AT sarresophie lostintheshadowsreflectionsonthedarksideofcoproduction
AT papouliasstanconstantina lostintheshadowsreflectionsonthedarksideofcoproduction
AT knowlessarah lostintheshadowsreflectionsonthedarksideofcoproduction
AT robertglenn lostintheshadowsreflectionsonthedarksideofcoproduction
AT beresfordpeter lostintheshadowsreflectionsonthedarksideofcoproduction
AT rosediana lostintheshadowsreflectionsonthedarksideofcoproduction
AT carrsarah lostintheshadowsreflectionsonthedarksideofcoproduction
AT kaurmeerat lostintheshadowsreflectionsonthedarksideofcoproduction
AT palmervictoriaj lostintheshadowsreflectionsonthedarksideofcoproduction